Plasmonic nanoparticle amyloid corona for screening Aβ oligomeric aggregate-degrading drugs

Abstract

Effective screening of drugs to treat amyloid oligomeric aggregates associated with Alzheimer’s is needed for drug development. Here the authors report on the creation of an amyloid corona around a plasmonic nanoparticle to monitor amyloid degradation when exposed to potential drugs and demonstrate application.